News
Novo Nordisk teams with telehealth firms Hims, Ro to sell Wegovy at lower price
Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth platforms. The strategy comes as rival Eli Lilly & Co. is working with telehealth firms to distribute lower-cost vials of its own obesity medication,
Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...
9hon MSN
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.
Novo Nordisk is expanding access to its GLP-1 drug Wegovy via telehealth, partnering with Hims and Hers, Ro, and LifeMD.
Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans.
A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.
Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback